一、企業(yè)概況：

　　       山西康欣藥業(yè)有限公司前身是文水縣國營(yíng)制藥廠(chǎng)，建廠(chǎng)于１９７１年，２００１年改制為股份制企業(yè)，公司占地面積３萬(wàn)平方米，現有資產(chǎn)２４００萬(wàn)元，全公司職工１６０人，大中專(zhuān)以上學(xué)歷５８人，占全體員工數３４．１％，其中高中級職稱(chēng)１２人，初級職稱(chēng)６５人，醫藥專(zhuān)業(yè)技術(shù)人員６２人。２００１年實(shí)現銷(xiāo)售收入１２０６萬(wàn)元，實(shí)現利稅１７１萬(wàn)元，２００２年實(shí)現銷(xiāo)售收入１６５０萬(wàn)元，實(shí)現利稅１７９萬(wàn)元。

　　二、項目概況：

　　       １、產(chǎn)品及規模：

　　       年產(chǎn)０．５ｇ／片的腦珍片３億片。

　　       ２、原材料來(lái)源及市場(chǎng)分析：

　　       山西是中藥材重點(diǎn)產(chǎn)地。中藥材和輔料的供應充足。

　　       真菌類(lèi)藥品，能有效增強人體免疫力，能增強身體抵抗力，還是人們防病的良藥，其市場(chǎng)前景看好，在日本已有用生物技術(shù)的方法生產(chǎn)人參和紫草的品種 并以保健品和化妝品推向市場(chǎng)，創(chuàng )造了較好的效益，故本品在東南亞及海外市場(chǎng)有很大的市場(chǎng)潛力。

　　       ３、項目建設地址及前期工作進(jìn)展：

　　       項目建設地址為文水縣縣城，該項目已立項，準備前期工作。

　　       ４、項目總投資及資金來(lái)源：

　　       該項目總投資為５７００萬(wàn)元，擬用外資４８０萬(wàn)美元，折合人民幣４０００萬(wàn)元。

　　       ５、合作方式：合資、合作。

　　       ６、項目經(jīng)濟效益預測：

　　       項目實(shí)施后，年銷(xiāo)售收入２６７００萬(wàn)元，年利稅總額５５８６萬(wàn)元，投資利潤率６５．２９％，投資利稅率１０２．５５％，投資回收３．６２期年。

　　三、聯(lián)系方式：

　　       項目聯(lián)系人：康富保

　　　　電話(huà)：０３５８－３０２２３３０　

　　　　傳真：０３５８－３０２２３３０　

　　　　地址：文水縣城

　　　　郵編：０３２１００

　　

　　

　　

　　

　?。裕颍幔洌椋簦椋铮睿幔?/span> Ｃｈｉｎｅｓｅ Ｍｅｄｉｃｉｎｅ

　?。校颍铮悖澹螅螅椋睿?/span> Ｐｒｏｊｅｃｔ

　?。桑?/span> Ｇｅｎｅｒａｌ Ｓｉｔｕａｔｉｏｎ ｏｆ Ｐｒｏｊｅｃｔ Ｕｎｉｔ

　　       Kangxin Pharmaceutical Co., Ltd of Shanxi was once a state-owned factory founded in 1971. It is reorganized as a joint-stock enterprise in 2001. It covers an area of 30,000 m with staff and workers 160 in which 58 are graduates from colleges and universities making up 34.1% of the total, those with middle and high title of technical post 12, primary 65 and technicians 62. The annual sales income in 2001 was 12,060,000 yuan, profit and tax 1,710,000

　　yuan. Those in 2002 was 16,500,000 yuan and 1,790,000 yuan respectively.

　?。桑桑?/span> Ｇｅｎｅｒａｌ Ｓｉｔｕａｔｉｏｎ ｏｆ Ｐｒｏｊｅｃｔ Ｕｎｉｔ

　　       1. Products and Scale

　　       To produce 300,000,000 Naozhen tablets (0.5g/tablet) yearly

　　       2. Raw Material and Marketing

　　       Shanxi is rich in Chinese medicine, and the raw and additional material can be sufficiently supplied. Fungus medicine can improve immunity of human beings and build up one's resistance to disease. It can also help in disease prevention. It will find a big market. In Japan, ginseng and Asian puccoon have been grown with biological technology. Its products as health protection goods and cosmetics are selling well. From the above, Naozhen tablets will find a big market in Southeast Asian and overseas markets.

　　       3. Location and Implementation in Earlier Stage

　　       It is located in Wenshui County. The project is approved and under preparation.

　　       4. Investment and Capital

　　       The total investment is 57,000,000 yuan in which 4,800,000 US dollars( 40,000,000 yuan) is to be introduced.

　　       5. Cooperation Mode

　　       Joint-venture or cooperation

　　       6. Benefit Analysis

　　       The annual sales income will be 267,000,000 yuan, the profit and tax 55,860,000 yuan, rate of profit 65.29%, rate of profit and tax 102.55%, investment recovery period 3.62 years

　?。桑桑桑?/span> Ｃｏｎｔａｃｔ Ｆｏｒｍ

　　       Contact Man: Kang Fubao

　　       Tel: 0358-3022330

　　       Fax: 0358-3022330

　　       Add: Wenshui County, Shanxi Province

　　       P.C: 032100